HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhiyuan Zhong Selected Research

Polo-Like Kinase 1

10/2021Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo.
1/2019Selective Cell Penetrating Peptide-Functionalized Envelope-Type Chimeric Lipopepsomes Boost Systemic RNAi Therapy for Lung Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhiyuan Zhong Research Topics

Disease

144Neoplasms (Cancer)
03/2024 - 06/2007
21Breast Neoplasms (Breast Cancer)
10/2022 - 05/2011
16Lung Neoplasms (Lung Cancer)
01/2022 - 06/2015
14Hepatocellular Carcinoma (Hepatoma)
10/2022 - 08/2011
12Glioblastoma (Glioblastoma Multiforme)
11/2022 - 12/2014
11Melanoma (Melanoma, Malignant)
10/2022 - 01/2017
7Multiple Myeloma
11/2023 - 11/2017
7Glioma (Gliomas)
01/2022 - 12/2014
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024 - 10/2017
6Neoplasm Metastasis (Metastasis)
12/2022 - 04/2019
5Triple Negative Breast Neoplasms
07/2023 - 01/2017
5Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2018
4Prostatic Neoplasms (Prostate Cancer)
10/2023 - 04/2007
4Inflammation (Inflammations)
03/2023 - 01/2015
3Hematologic Neoplasms (Hematological Malignancy)
03/2023 - 11/2017
3Bites and Stings (Sting)
01/2023 - 01/2022
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2018
3Body Weight (Weight, Body)
01/2021 - 01/2017
3Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 11/2018
3Liver Neoplasms (Liver Cancer)
10/2020 - 03/2015
3Myocardial Infarction
01/2017 - 04/2007
2Leukemia
08/2023 - 10/2017
2Rheumatoid Arthritis
03/2023 - 02/2022
2Infections
01/2023 - 11/2022

Drug/Important Bio-Agent (IBA)

36MicellesIBA
01/2022 - 10/2009
35Peptides (Polypeptides)IBA
01/2023 - 07/2013
35Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022 - 01/2009
25Proteins (Proteins, Gene)FDA Link
01/2023 - 04/2007
23Hyaluronic Acid (Hyaluronan)IBA
10/2021 - 06/2014
14LigandsIBA
01/2022 - 10/2013
14Ethylene Glycol (Monoethylene Glycol)IBA
10/2021 - 08/2011
13IntegrinsIBA
10/2023 - 12/2014
13DisulfidesIBA
10/2023 - 02/2017
12Small Interfering RNA (siRNA)IBA
01/2023 - 04/2007
12ProdrugsIBA
01/2022 - 05/2011
11NanogelsIBA
04/2019 - 05/2011
10Docetaxel (Taxotere)FDA Link
10/2023 - 07/2017
8Paclitaxel (Taxol)FDA LinkGeneric
07/2023 - 03/2010
8PolymersIBA
01/2022 - 04/2007
7Transferrin (beta 2 Transferrin)IBA
01/2024 - 06/2014
7CytokinesIBA
03/2023 - 01/2015
7cyclic arginine-glycine-aspartic acid peptideIBA
01/2023 - 06/2014
7caprolactoneIBA
01/2017 - 08/2011
7Galactose (Galactopyranose)FDA LinkGeneric
09/2015 - 08/2011
6Maytansine (Maitansine)IBA
12/2022 - 11/2016
5ErbB Receptors (EGF Receptor)IBA
10/2022 - 07/2017
5Glutathione (Reduced Glutathione)IBA
10/2022 - 11/2016
5Granzymes (Granzyme)IBA
01/2022 - 06/2015
5Apolipoproteins E (ApoE)IBA
01/2022 - 11/2018
5Folic Acid (Vitamin M)FDA LinkGeneric
01/2022 - 06/2014
5liposomal doxorubicin (Doxil)FDA Link
01/2018 - 10/2016
5Liposomes (Liposome)IBA
01/2018 - 10/2012
5polyethylene glycol bis(succinimidyl succinate)IBA
01/2017 - 08/2013
4Vincristine (Oncovin)FDA LinkGeneric
08/2023 - 10/2021
4AntigensIBA
08/2023 - 10/2021
4Methotrexate (Mexate)FDA LinkGeneric
03/2023 - 09/2015
4Messenger RNA (mRNA)IBA
01/2023 - 12/2018
4Therapeutic UsesIBA
01/2023 - 06/2007
4EnzymesIBA
09/2022 - 01/2018
4Immunoconjugates (Immunoconjugate)IBA
12/2021 - 11/2018
4DNA (Deoxyribonucleic Acid)IBA
10/2021 - 06/2010
4Thioctic Acid (Lipoic Acid)IBA
11/2020 - 05/2015
4Cytochromes c (Cytochrome c)IBA
10/2020 - 08/2016
4AcidsIBA
01/2018 - 08/2013
4HydrogelsIBA
07/2016 - 08/2007
3VaccinesIBA
03/2024 - 10/2021
3NanovaccinesIBA
03/2024 - 10/2021
3Proteasome InhibitorsIBA
11/2023 - 10/2018
3Immunologic Adjuvants (Immunologic Adjuvant)IBA
01/2023 - 01/2022
3InterferonsIBA
01/2023 - 09/2022
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 01/2018
3Cancer VaccinesIBA
01/2023 - 10/2021
3BI 6727IBA
09/2022 - 01/2021
3acetyl- lysyl- prolyl- seryl- seryl- prolyl- prolyl- glutamyl- glutamic acid amideIBA
01/2022 - 01/2020
3ApolipoproteinsIBA
01/2022 - 11/2018
3Oncogene Proteins (Oncogene Protein)IBA
10/2021 - 12/2018
3Nucleic AcidsIBA
10/2021 - 05/2011
3SaporinsIBA
01/2020 - 07/2018
3GE11 peptideIBA
01/2020 - 12/2017
3IodineIBA
11/2019 - 01/2019
3Cell-Penetrating PeptidesIBA
01/2019 - 01/2018
3Matrix Metalloproteinases (MMPs)IBA
10/2017 - 01/2017
3Glutamic Acid (Glutamate)FDA Link
11/2016 - 09/2015
2carfilzomibIBA
11/2023 - 01/2020
2daratumumabIBA
08/2023 - 10/2021
2GemcitabineFDA Link
07/2023 - 01/2022
2MicroRNAs (MicroRNA)IBA
01/2023 - 10/2021
2benzeneboronic acidIBA
01/2023 - 11/2022
2Cetuximab (Erbitux)FDA Link
12/2022 - 10/2022
2Radioisotopes (Radionuclides)IBA
11/2022 - 05/2019
2Pemetrexed (MTA)FDA Link
10/2022 - 01/2018

Therapy/Procedure

72Therapeutics
10/2023 - 10/2009
50Drug Therapy (Chemotherapy)
10/2022 - 08/2011
12Immunotherapy
03/2024 - 10/2021
4Radiotherapy
01/2023 - 11/2019
4Intravenous Injections
10/2022 - 12/2016
3Precision Medicine
11/2022 - 12/2016
3RNAi Therapeutics
10/2021 - 12/2018
3Injections
01/2017 - 04/2007
2Photochemotherapy (Photodynamic Therapy)
01/2023 - 11/2021